Assessing risk in hypertrophic cardiomyopathy.
Cannon
Richard O
RO
National Heart, Lung, and Blood Institute, Bethesda, Md., USA.
D000818:Animals; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications* / Q000235:genetics / Q000503:physiopathology; D003326:Coronary Circulation / Q000187:drug effects*; D004176:Dipyridamole / Q000494:pharmacology*; D006801:Humans; D011379:Prognosis; D012307:Risk Factors; D014665:Vasodilator Agents / Q000494:pharmacology*
D014665:Vasodilator Agents; D004176:Dipyridamole